Table 1 Distribution of disease categories
Groups | Findings and number of dogs |
|---|---|
SRMA untreated (SRMA) | Dogs with fever, cervical pain, neutrophilic leukocytosis and pleocytosis. These dogs were not pre-treated with glucocorticosteroid (n = 36) |
SRMA relapse (SRMA R) | Dogs with a previous diagnosis of SRMA in which clinical signs recurred despite glucocorticosteroid treatment (n = 9) |
SRMA therapy (SRMA Th) | Dogs with previous diagnosis of SRMA under long-term glucocorticosteroid treatment. These dogs did not show any clinical signs at the time of sampling (n = 20) |
Idiopathic epilepsy (IE) | Dogs with clinical, CSF, MRI findings consistent with idiopathic epilepsy (n = 22) |
Meningoencephalomyelitides (ME) | Dogs with clinical, CSF, MRI and/or pathological findings consistent with meningoencephalomyelitides: granulomatous meningoencephalomyelitis (n = 14), necrotising encephalitides (n = 1), meningoencephalomyelitis of unknown origin (n = 8), infectious encephalitides (n = 24) |
Miscellaneous non-inflammatory CNS diseases (CNS-Mix). | Dogs with miscellaneous not primarily inflammatory neurological diseases: intervertebral disc disease (n = 9), neoplasia of the CNS (n = 24), cerebrovascular disease (n = 4), degenerative myelopathy (n = 1) |
Systemic inflammatory diseases (Syst. Inflam.) | Dogs affected with systemic inflammatory diseases, but not suffering from neurological conditions (n = 16) |
Healthy | Healthy dogs (n = 20) |